Labshake search
Citations for R&D Systems :
1201 - 1250 of 4242 citations for 9 10 Dihydro 4H benzo 4 5 cyclohepta 1 2 b thiophen 4 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Developmental Biology 2023Quote: ... 5 ng/ml BMP7 (R&D Systems, cat# 354-BP-500/CF), and 50 ng/ml BMP12/GDF7 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... plus 5 ng/mL of recombinant mouse IL-18 (R&D Systems). To retain intracellular mediators for downstream cytofluorimetric analyses ...
-
bioRxiv - Immunology 2023Quote: BMDMs were primed with murine IFNγ (5 ng/ml, R&D systems) for 16 h ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 5 ng/ml human VEGF (R&D Systems Cat#. 293-VE). The 2-day-old EBs were dissociated and 6 × 104 cells were seeded onto individual wells of a 24-well plate coated with 0.1% gelatine in EC Induction Medium consisting of StemPro-34 medium (Gibco #10639011) ...
-
bioRxiv - Molecular Biology 2023Quote: ... After addition of 5 µl ISG15-AMC (R&D Systems #UL-553) substrate ...
-
bioRxiv - Developmental Biology 2024Quote: ... BPEL containing WNT inhibitor XAV939 (5 μmol/L, R&D Systems 3748) was used to refresh cells ...
-
Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutationsbioRxiv - Genomics 2024Quote: ... or 5 µg of AREG neutralizing antibody (R&D Systems, MAB262-SP) or an equivalent volume of PBS ...
-
bioRxiv - Immunology 2024Quote: ... primary dFBs were treated with IFNγ (5 ng/ml, R&D Systems) or PBS control for 2 hours ...
-
bioRxiv - Neuroscience 2024Quote: ... myogenic factor 5 (MYF5) (mouse monoclonal, MAB4027, R&D Systems, Minneapolis, USA), myosin heavy chain (MYHC ...
-
bioRxiv - Immunology 2024Quote: ... IL-5 and IL-13 were measured by ELISA (R&D systems). Results were normalized to cell number using CyQuant cell proliferation assay (Invitrogen ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 mM ATP) with 0.1 μM recombinant yeast E1 (R&D Systems), ...
-
bioRxiv - Immunology 2022Quote: ... monocytes were cultivated for 6 days with a change of medium at day 3 in RPMI 1640/10% human serum and 10 ng/ml recombinant M-CSF (R&D Systems). At day 6 the medium was replaced with RPMI 1640/10% human serum and used for experiments on day 7.
-
bioRxiv - Cell Biology 2022Quote: ... and seeded in RPMI 1640 supplemented with 10% serum and 10 ng/ml recombinant macrophage colony-stimulating factor (M-CSF; R&D Systems) for 3 days ...
-
bioRxiv - Bioengineering 2020Quote: ... The ELISA coating buffer (1× PBS, DY006), concentrated wash buffer (WA126), and concentrated reagent diluent (10% BSA in 10× PBS, DY995) were purchased from R&D Systems. The human serum was purchased from Millipore Sigma (H4522-20ML) ...
-
bioRxiv - Cell Biology 2021Quote: ... and inserts were immersed in 500 µL RPMI media containing 10% FBS in the absence or presence of 10 ng/mL PDGF-AA or PDGF-BB ligand (R&D Systems) for 24 h ...
-
bioRxiv - Cancer Biology 2021Quote: MDA231-LM2 cells in DMEM with 10% FBS were cultured with or without incremental dosages (10-200 ng/ml) of recombinant OPG (R&D Systems) for 30 min ...
-
bioRxiv - Microbiology 2022Quote: ... + 10% heat-inactivated fetal bovine serum (HyClone) (hereafter referred to as “infection medium”) containing 10 nM human IL-8 (R&D Systems) and left to adhere to tissue culture-treated plastic coverslips (Sarstedt ...
-
bioRxiv - Immunology 2023Quote: ... 3129), for CCR5, with Maraviroc (10 μM, 3756) and for blocking CXCR3 with AMG487 (10 μM, 4487) all from R&D Systems, at 37°C ...
-
bioRxiv - Cell Biology 2020Quote: ... supplemented with 10% fetal bovine serum (R&D Systems) and 1% Penicillin/Streptomycin/Kanamycin (SIGMA and GIBCO) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 30 µM of EG00229 (R&D Systems, 6986/10) for 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 10 μM Y-27632 (R&D Systems) for the first 24 hours ...
-
bioRxiv - Microbiology 2019Quote: ... and 10 ng/ml rmM-CSF (R&D Systems). Macrophages were removed from the plate following incubation with cold PBS and plated in 24-well plates at 0.25×106/well ...
-
bioRxiv - Immunology 2022Quote: ... containing 10% FBS (R&D Systems, Flowery Branch, GA) and penicillin (100 U/mL) ...
-
bioRxiv - Molecular Biology 2020Quote: ... and BMP-10 were obtained from R&D Systems, PROMOCELL or produced in-house ...
-
bioRxiv - Immunology 2022Quote: ... IL4 (10 ng/mL, M2-like, R&D Systems) or medium (M0 macrophages) ...
-
bioRxiv - Neuroscience 2019Quote: ... CNTF and GDNF (10 ng/mL, R&D systems). For imaging analysis ...
-
bioRxiv - Neuroscience 2019Quote: ... supplemented with BDNF 10 μg/L (R&D systems), human NT-3 10 μg/L (ReproTech) ...
-
bioRxiv - Immunology 2021Quote: ... containing 10% fetal bovine serum (FBS, R&D Systems), 1% penicillin-streptomycin (P/S ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml OSM (R&D Systems #8475-OM), 20 ng/ml BMP2 (R&D Systems #355-BM ...
-
bioRxiv - Systems Biology 2020Quote: ... ROCK inhibitor Y-27632 (10 μM, R&D Systems) was added for the first two days of culture only ...
-
bioRxiv - Bioengineering 2020Quote: ... ROCK inhibitor Y-27632 (10 μM, R&D Systems) was added for the first two days of ISC culture only ...
-
bioRxiv - Biochemistry 2021Quote: ... supplemented with 10% fetal bovine serum (R&D systems) and 1% penicillin-streptomycin (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL recombinant GDNF (R&D Systems, USA), 10 ng/mL recombinant human IGF-1 (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL recombinant BDNF (R&D Systems, USA), 10 ng/mL recombinant GDNF (R&D Systems ...
-
bioRxiv - Bioengineering 2021Quote: ... with 10% fetal calf serum (R&D Systems, S11150). For collagen (Corning ...
-
bioRxiv - Immunology 2022Quote: ... with 10% Fetal bovine serum (R&D systems S11550) as well as 1% penicillin/streptomycin (ThermoFisher Scientific 15070063 ...
-
bioRxiv - Cell Biology 2022Quote: ... media with 10% fetal bovine serum (R&D systems), 1% Penicillin-Streptomycin (Corning ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 10 µM Y-27632 (R&D Systems, 1254), and plated in transwell inserts (Griener Thincert ...
-
bioRxiv - Immunology 2022Quote: ... and 12 ng/ml IL-10 (R&D Systems) in order to promote the differentiation into plasmablasts (“2nd step differentiation cocktail”)8 ...
-
bioRxiv - Immunology 2022Quote: ... and 12 ng/ml IL-10 (R&D Systems).
-
bioRxiv - Molecular Biology 2020Quote: ... and TNF-α (10 ng/ml, R&D Systems) in the presence of IncuCyte Caspase-3/7 green reagent (IncuCyte ...
-
bioRxiv - Neuroscience 2021Quote: ... with 10 mg/kg methoxy-X04 (R&D Systems). Mice were perfused with PBS 24 hours after injection and cortical and hippocampal tissues were dissected and processed into single-cell suspension for staining as described above except the antibodies used for FACS were ...
-
bioRxiv - Neuroscience 2021Quote: ... and SB-431542 (10 μM, R&D Systems, 1614). Feeder-free hCS differentiation was performed as previously described (Yoon et al. ...
-
bioRxiv - Cell Biology 2021Quote: ... and 10 ng/ml recombinant NRG1 (R&D Systems). Where indicated ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 10% FBS (R&D Systems, Minneapolis, MN), 1X GlutaMAX (Gibco) ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with BDNF (10 ng/mL, R&D Systems), GDNF (10 ng/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... media with 10% fetal bovine serum (R&D systems), 1% Penicillin-Streptomycin (Corning ...
-
bioRxiv - Cancer Biology 2019Quote: ... 10 ng/ml bFGF (R&D Systems; Minneapolis, MN), and 0.4% BSA using 6-well ultra-low attachment plates (Corning Life Sciences ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant Human NT3 (10 ng/ml, R&D Systems) and Doxycycline (5 μM ...